Pharmacokinetics and pharmacodynamics of acetazolamide in patients with transient intraocular pressure elevation

European Journal of Clinical Pharmacology

Volumn 54, Issue 1, 1998, Pages 63-68

  Yano, I ^a   Takayama, A ^a   Takano, M ^a   Inatani, M ^b   Tanihara, H ^b   Ogura, Y ^b   Honda, Y ^b   Inui, K ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Acetazolamide; Intraocular pressure

Indexed keywords

ACETAZOLAMIDE; ANTIGLAUCOMA AGENT; CARBONATE DEHYDRATASE INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG METABOLISM; FEMALE; GLAUCOMA; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; INTRAOCULAR PRESSURE ABNORMALITY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ACETAZOLAMIDE; AGED; AGED, 80 AND OVER; CARBONIC ANHYDRASE INHIBITORS; CREATININE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INTRAOCULAR PRESSURE; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED;

EID: 0031970406     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050422     Document Type: Article

References (15)

1. Hoskins HD Jr, Kass MA (1989) Becker-Shaffer's Diagnosis and therapy of the glaucomas. 6th edn. Mosby. St Louis
2. Epstein DL, Grant WM (1977) Carbonic anhydrase inhibitor side effects. Arch Ophthalmol 95: 1378 1382
3. Friedland BR, Mallonee J, Anderson DR (1977) Short-term dose response characteristics of acetazolamide in man. Arch Ophthalmol 95: 1809 1812
4. Lehmann B, Linner E. Wistrand PJ (1969) The pharmacokinetics of acetazolamide in relation to its use in the treatment of glaucoma and to its effects as an inhibitor of carbonic anhydrases. In: Rospe G (ed) Schering workshop in phurmacokinetics, advances in the biosciences 5. Pergamon. New York, pp 197 217
5. Alm A, Berggren L, Hartvig P, Roosdorp M (1982) Monitoring acetazolamide treatment. Acta Ophthalmol (Copenh) 60: 24 34
6. Berson FG, Epstein DL, Grant WM, Hutchinson BT, Dobbs PC (1980) Acetazolamide dosage forms in the treatment of glaucoma. Arch Ophthalmol 98: 1051 1054
7. Wistrand PJ (1984) The use of carbonic anhydrase inhibitors in ophthalmology and clinical medicine. Ann N Y Acad Sci 429: 609 619
8. Schwenk MH, St Peter WL, Meese MG, Singhai PC (1995) Acetazolamide toxicity and pharmacokinetics in patients receiving hemodialysis. Pharmacotherapy 15: 522 527
9. Chapron DJ, Sweeney KR, Feig PU. Kramer PA (1985) Influence of advanced age on the disposition of acetazolamide. Br J Clin Pharmacol 19: 363 371
10. Chapron DJ, Gomolin IH, Sweeney KR (1989) Acetazolamide blood concentrations are excessive in the elderly: propensity for acidosis and relationship to renal function. J Clin Pharmacol 29: 348 353
11. Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16: 31 41
12. Chambers DM, White MH, Kostenbauder HB (1981) Efficient extraction and reversed-phase high-performance liquid chro-matography ultraviolet quantitation of acetazolamide in serum. J Chromatogr 225: 231 235
13. Sheiner LB, Rosenberg B, Marathe VV (1977) Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. J Pharmacokinet Biopharm 5: 445-479
14. Beal SL, Boeckmann AJ, Sheiner LB (1992) NONMEM users guides. NONMEM Project Group, University of California. San Francisco
15. Bennett WM, Aronoff GR. Golper TA, Morrison G. Brater DC, Singer I (1994) Drug prescribing in renal failure: dosing guidelines for adults. 3rd edn. American College of Physicians, Philadelphia